Equity Analysis /
United States of America

US : Sarepta Therapeutics, Inc. - SRPT | 3Q Results: Base Business Strength Continues; All Eyes On SRP-9001 Crossover Data in Early 22

    Danielle Brill
    CGS-CIMB
    3 November 2021
    Published by